Commentary: The Shrinking Role of the Freestyle Aortic Bioprostheses in Younger Patients
In this issue of Seminars in Thoracic and Cardiovascular Surgery, Khazaal and colleagues from Grand Rapids present their single center long-term experience with the Freestyle porcine bioprosthesis (Medtronic Inc., Minneapolis MN) in younger patients.1 Since its FDA-approval in 1997, the Freestyle bioprosthesis has become part of the armamentarium for aortic valve and aortic root replacement. Like other stentless bioprostheses, the main advantage it offers is favorable hemodynamics due to larger effective orifice area.
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Leora B. Balsam Tags: ADULT – Commentary Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Heart Valve Surgery